Impaired endothelial function in preadolescent children with type 1 diabetes

Ghufran S Babar1, Hanaa Zidan, Michael E Widlansky

  • 1Department of Pediatric Endocrinology, Children’s Mercy Hospital, Kansas City, Missouri, USA.

Diabetes Care
|February 4, 2011
PubMed

Insights

Preadolescent children with type 1 diabetes show early signs of vascular inflammation and impaired blood vessel function, indicating increased future cardiovascular risk. These findings highlight the importance of monitoring vascular health in young diabetics.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Research
  • Vascular Biology

Background:

  • Type 1 diabetes (T1D) in children can lead to long-term complications, including cardiovascular disease.
  • Early detection of vascular dysfunction and inflammation is crucial for risk stratification in pediatric T1D.
  • Endothelial dysfunction and systemic inflammation are recognized predictors of future cardiovascular events.

Purpose of the Study:

  • To assess endothelial dysfunction using flow-mediated dilation (FMD) and carotid intima-media thickness (c-IMT).
  • To investigate vascular inflammatory biomarkers in preadolescent children with T1D.
  • To establish the relationship between T1D, inflammation, and early vascular changes.

Main Methods:

  • A study involving 21 preadolescent children with T1D and 15 healthy siblings.
  • Measurements included fasting plasma glucose (FPG), HbA1c, lipid profile, hs-CRP, fibrinogen, homocysteine, and RBC folate.
  • Vascular assessment via high-resolution ultrasound for c-IMT and brachial artery FMD%.

Main Results:

  • Children with T1D exhibited higher FPG, HbA1c, and hs-CRP levels compared to controls.
  • No significant differences were observed in BMI, homocysteine, fibrinogen, RBC folate, or c-IMT between groups.
  • Preadolescent T1D patients demonstrated significantly lower FMD% (indicating endothelial dysfunction) than healthy siblings.

Conclusions:

  • Preadolescent children with T1D show evidence of low-grade vascular inflammation and reduced FMD.
  • Endothelial dysfunction and systemic inflammation are present early in T1D, even before structural changes like increased c-IMT.
  • These findings suggest that early cardiovascular risk is established in childhood T1D, necessitating proactive management.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...